Harper is excited to incorporate Semaglutide and Tirzepatide weight loss injections into her comprehensive, personalized weight loss programs, offering patients a powerful tool to achieve their weight loss goals and reclaim their health
Reduced Appetite : Semaglutide effectively curbs hunger, making it easier to stick to a diet
References: MHRA/EMC Summary of Product Characteristics: Mounjaro (tirzepatide) EMA European Public Assessment Report: Mounjaro (tirzepatide) Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, a peptide-based medication that mimics naturally occurring gut hormones to regulate appetite and blood glucose levels
Exercise timing influences multi-tissue metabolome and skeletal muscle proteome profiles in type 2 diabetic patients - A randomized crossover trial
Online anecdotes mention doses anywhere from about 0.05 mg up to 0.125 mg of semaglutide (roughly 20%50% of the typical starting dose) taken weekly or even more frequently
Final Thoughts GLP-1 medications offer a wealth of benefits beyond weight loss, making them a versatile tool for improving overall health
